Carl Fichtenbaum, MD
Infectious Disease · Cincinnati, OHNPI 1073578951
Payments from drug & device makers
Across 407 payments — averaging $3930.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$952K
- Gilead$174K
- GSK$170K
- Modernatx, Inc.$64K
- Amgen$56K
- Pfizer$56K
- plus $129K from 8 others
Across 18 payments — averaging $874.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$13K
- Viiv Healthcare Company$2K
- GSK$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 192 | $951,551 |
| Gilead | 79 | $173,598 |
| GSK | 38 | $170,068 |
| Modernatx, Inc. | 14 | $63,911 |
| Amgen | 8 | $55,674 |
| Pfizer | 4 | $55,568 |
| Merck | 56 | $49,574 |
| Janssen Research & Development, LLC | 8 | $43,147 |
| AbbVie | 2 | $23,825 |
| Eli Lilly | 1 | $10,073 |
| Theratechnologies Inc. | 2 | $2,514 |
| La Jolla Pharmaceutical Company | 1 | $146 |
| Janssen Products, LP | 1 | $99 |
| Johnson & Johnson | 1 | $28 |
How this compares
$1,599,777 in reported general payments places this provider in the 95th percentile of 308 infectious disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Cincinnati
- Moises Huaman JooCincinnati$1.2M
- John CafardiCincinnati$719K
- Judith FeinbergCincinnati$113K
- Silvania NgCincinnati$33K
- Scott FriedstromCincinnati$15K
- Senu ApewokinCincinnati$11K
- Joseph KlingenCincinnati$7K
- Francisco Fernandez-GonzalezCincinnati$7K
- Robert SalataCleveland$2.8M
- Curtis DonskeyCleveland$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.